
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Methylphenidate: Difference between revisions
Jump to navigation
Jump to search
>Miceneme personal experience and reading through erowid experience reports, euphoria/peak only persists for ~45 mins max and then fades into residual stimulation, the nasty side effects associated with methylphenidate kick in right after the peak as well |
>Isaak |
||
(9 intermediate revisions by 5 users not shown) | |||
Line 40: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon=Methylphenidate, Concerta, Methylin, Ritalin, Equasym XL | |NameCommon=[[common name::Methylphenidate]], [[common name::Concerta]], [[common name::Methylin]], [[common name::Ritalin]], [[common name::Equasym XL]] | ||
|NameSubstitution=Methylphenidate | |NameSubstitution=Methylphenidate | ||
|NameSystematic=Methyl 2-phenyl-2-piperidin-2-ylacetate | |NameSystematic=Methyl 2-phenyl-2-piperidin-2-ylacetate | ||
Line 69: | Line 69: | ||
|OralROA_Collapsed=false | |OralROA_Collapsed=false | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability=11-52%<ref name="Health Canada - Ritalin">"https://s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/483/original/Health_Canada_-_Ritalin.PDF?1556050208"</ref> | ||
|OralROA_Threshold=[[Oral threshold dose::5]] [[Oral dose units::mg]] | |OralROA_Threshold=[[Oral threshold dose::5]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::10]] - [[Oral max light dose::20]] mg | |OralROA_Light=[[Oral min light dose::10]] - [[Oral max light dose::20]] mg | ||
Line 77: | Line 78: | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min total time:: | |OralROA_Duration=[[Oral min total time::2.5]] - [[Oral max total time::4]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time:: | |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::60]] [[Oral onset time units::minutes]] | ||
|OralROA_Comeup=[[Oral min comeup time::20]] - [[Oral max comeup time:: | |OralROA_Comeup=[[Oral min comeup time::20]] - [[Oral max comeup time::45]] [[Oral comeup time units::minutes]] | ||
|OralROA_Peak=[[Oral min peak time:: | |OralROA_Peak=[[Oral min peak time::60]] - [[Oral max peak time::90]] [[Oral peak time units::minutes]] | ||
|OralROA_Offset=[[Oral min offset time:: | |OralROA_Offset=[[Oral min offset time::45]] - [[Oral max offset time::60]] [[Oral offset time units::minutes]] | ||
|OralROA_Aftereffects=[[Oral min afterglow time::2]] - [[Oral max afterglow time::6]] [[Oral afterglow time units::hours]] | |OralROA_Aftereffects=[[Oral min afterglow time::2]] - [[Oral max afterglow time::6]] [[Oral afterglow time units::hours]] | ||
Line 89: | Line 90: | ||
|InsufflatedROA_Caption= | |InsufflatedROA_Caption= | ||
|InsufflatedROA_Bioavailability= | |InsufflatedROA_Bioavailability= | ||
|InsufflatedROA_Threshold=[[Insufflated threshold dose:: | |InsufflatedROA_Threshold=[[Insufflated threshold dose::1]] [[Insufflated dose units::mg]] | ||
|InsufflatedROA_Light=[[Insufflated min light dose:: | |InsufflatedROA_Light=[[Insufflated min light dose::2]] - [[Insufflated max light dose::10]] mg | ||
|InsufflatedROA_Common=[[Insufflated min common dose:: | |InsufflatedROA_Common=[[Insufflated min common dose::10]] - [[Insufflated max common dose::30]] mg | ||
|InsufflatedROA_Strong=[[Insufflated min strong dose::30]] - [[Insufflated max strong dose::60]] mg | |InsufflatedROA_Strong=[[Insufflated min strong dose::30]] - [[Insufflated max strong dose::60]] mg | ||
|InsufflatedROA_Heavy=[[Insufflated heavy dose::60]] mg + | |InsufflatedROA_Heavy=[[Insufflated heavy dose::60]] mg + |
Revision as of 15:54, 22 January 2025
SubstanceBox/Methylphenidate | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common names | Methylphenidate, Concerta, Methylin, Ritalin, Equasym XL | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Substitutive name | Methylphenidate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systematic name | Methyl 2-phenyl-2-piperidin-2-ylacetate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Psychoactive class | Stimulant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chemical class | Phenidate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|